secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2022-12-07T23:59:59+00:00
Accession:  0001493152-22-034767
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine gets 180-day Nasdaq extension to June 5, 2023 for $1 bid compliance
----------------------------------------------------------------------------

- Received Nasdaq notice granting additional 180 days, until June 5, 2023, to meet $1 minimum bid requirement.
- Failed to regain compliance during initial 180-day period that ended December 5, 2022.
- Eligible for extension because it meets other listing standards and has indicated intent to cure via reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315222034767/0001493152-22-034767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315222034767/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-034767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer